Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Miyazaki

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 3, 2013
p62/SQSTM1 differentially removes the toxic mutant androgen receptor via autophagy and inclusion formation in a spinal and bulbar muscular atrophy mouse modelHideki Doi, Hiroaki Adachi, Masahisa Katsuno, et al.
Human Molecular Genetics|February 20, 2014
Paeoniflorin eliminates a mutant AR via NF-YA-dependent proteolysis in spinal and bulbar muscular atrophyGenki Tohnai, Hiroaki Adachi, Masahisa Katsuno, et al.
Cancer Medicine|February 22, 2023
Up-regulation of secretory leukocyte protease inhibitor in human samples might have a potential role of predicting prostate cancer recurrence and progression after surgery and hormonal therapyYu Miyazaki, Takayuki Goto, Xin Li, et al.
The Prostate|September 3, 2015
Decreased expression of lysophosphatidylcholine (16:0/OH) in high resolution imaging mass spectrometry independently predicts biochemical recurrence after surgical treatment for prostate cancerTakayuki Goto, Naoki Terada, Takahiro Inoue, et al.
Nature Medicine|June 5, 2012
Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2Yu Miyazaki, Hiroaki Adachi, Masahisa Katsuno, et al.
Scientific Reports|March 13, 2019
Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancerTakayuki Sumiyoshi, Kei Mizuno, Toshinari Yamasaki, et al.
Nature Communications|January 31, 2013
Heat shock factor-1 influences pathological lesion distribution of polyglutamine-induced neurodegenerationNaohide Kondo, Masahisa Katsuno, Hiroaki Adachi, et al.
Science Advances|May 25, 2022
Actin-binding protein filamin-A drives tau aggregation and contributes to progressive supranuclear palsy pathologyKoyo Tsujikawa, Kohei Hamanaka, Yuichi Riku, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2021
Clinical Impact of Detecting Low-Frequency Variants in Cell-Free DNA on Treatment of Castration-Resistant Prostate CancerKei Mizuno, Takayuki Sumiyoshi, Takatsugu Okegawa, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 3, 2013
p62/SQSTM1 differentially removes the toxic mutant androgen receptor via autophagy and inclusion formation in a spinal and bulbar muscular atrophy mouse modelHideki Doi, Hiroaki Adachi, Masahisa Katsuno, et al.
Human Molecular Genetics|February 20, 2014
Paeoniflorin eliminates a mutant AR via NF-YA-dependent proteolysis in spinal and bulbar muscular atrophyGenki Tohnai, Hiroaki Adachi, Masahisa Katsuno, et al.
Cancer Medicine|February 22, 2023
Up-regulation of secretory leukocyte protease inhibitor in human samples might have a potential role of predicting prostate cancer recurrence and progression after surgery and hormonal therapyYu Miyazaki, Takayuki Goto, Xin Li, et al.
The Prostate|September 3, 2015
Decreased expression of lysophosphatidylcholine (16:0/OH) in high resolution imaging mass spectrometry independently predicts biochemical recurrence after surgical treatment for prostate cancerTakayuki Goto, Naoki Terada, Takahiro Inoue, et al.
Nature Medicine|June 5, 2012
Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2Yu Miyazaki, Hiroaki Adachi, Masahisa Katsuno, et al.
Scientific Reports|March 13, 2019
Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancerTakayuki Sumiyoshi, Kei Mizuno, Toshinari Yamasaki, et al.
Nature Communications|January 31, 2013
Heat shock factor-1 influences pathological lesion distribution of polyglutamine-induced neurodegenerationNaohide Kondo, Masahisa Katsuno, Hiroaki Adachi, et al.
Science Advances|May 25, 2022
Actin-binding protein filamin-A drives tau aggregation and contributes to progressive supranuclear palsy pathologyKoyo Tsujikawa, Kohei Hamanaka, Yuichi Riku, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2021
Clinical Impact of Detecting Low-Frequency Variants in Cell-Free DNA on Treatment of Castration-Resistant Prostate CancerKei Mizuno, Takayuki Sumiyoshi, Takatsugu Okegawa, et al.
Pageof 7